Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry

Fig. 1

Pulmonary function over 24 months (pirfenidone-treated population) (a) Mean (SD) percent predicted FVC, (b) Mean (SD) percent predicted DLco, and (c) Mean (SD) change from Month 0. Month 0 is the time of inclusion in the PROOF registry. Patients were included in the calculation if they had a lung function measurement available for the specified time point, regardless of whether they had a baseline measurement (a, b). For mean changes in pulmonary function from Month 0, patients were included in the calculation for a time point if they had an FVC or DLco measurement available for that time point and a corresponding measurement at Month 0 (c). DLco carbon monoxide diffusing capacity, FVC forced vital capacity, SD standard deviation

Back to article page